Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lacombe

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
Thrombosis and Haemostasis|December 1, 1996
Activation of coagulation and fibrinolysis in heatstrokeA Bouchama, F Bridey, M M Hammami, et al.
Oncogene|June 13, 2001
Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo)D Bouscary, C Lecoq-Lafon, S Chrétien, et al.
Leukemia|June 30, 2012
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AMLS Ettou, E Audureau, C Humbrecht, et al.
The Journal of Clinical Investigation|February 1, 1988
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidneyC Lacombe, J L Da Silva, P Bruneval, et al.
The Pediatric Infectious Disease Journal|October 26, 1999
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infectionsD Gendrel, J Raymond, J Coste, et al.
Virology|July 15, 1983
Genesis of a new spleen focus-forming virus: possible role of MCF virusesD Barbieri-Weill, D Mathieu-Mahul, F Gay, et al.
Leukemia|June 15, 2013
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromesS Mathis, N Chapuis, C Debord, et al.
Leukemia|July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulumE Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia|April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasmsO Kosmider, V Gelsi-Boyer, L Slama, et al.
Leukemia|June 13, 2008
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AMLS Park, N Chapuis, V Bardet, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Thrombosis and Haemostasis|December 1, 1996
Activation of coagulation and fibrinolysis in heatstrokeA Bouchama, F Bridey, M M Hammami, et al.
Oncogene|June 13, 2001
Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo)D Bouscary, C Lecoq-Lafon, S Chrétien, et al.
Leukemia|June 30, 2012
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AMLS Ettou, E Audureau, C Humbrecht, et al.
The Journal of Clinical Investigation|February 1, 1988
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidneyC Lacombe, J L Da Silva, P Bruneval, et al.
The Pediatric Infectious Disease Journal|October 26, 1999
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infectionsD Gendrel, J Raymond, J Coste, et al.
Virology|July 15, 1983
Genesis of a new spleen focus-forming virus: possible role of MCF virusesD Barbieri-Weill, D Mathieu-Mahul, F Gay, et al.
Leukemia|June 15, 2013
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromesS Mathis, N Chapuis, C Debord, et al.
Leukemia|July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulumE Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia|April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasmsO Kosmider, V Gelsi-Boyer, L Slama, et al.
Leukemia|June 13, 2008
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AMLS Park, N Chapuis, V Bardet, et al.
Pageof 24